55.92
price down icon0.30%   -0.17
after-market After Hours: 56.01 0.09 +0.16%
loading

Corcept Therapeutics Inc Stock (CORT) Forecast

The Corcept Therapeutics Inc (CORT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $29.22, representing a -47.75% decrease from the current price of $55.92. The highest analyst price target is $32.37, and the lowest is $26.06.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CORT Price Target
Average 33.25 (-40.53% Downside)
loading

Is Corcept Therapeutics Inc (CORT) A Buy Now?

Oscillators
Name Value Action
RSI(14) 61.47 Neutral
STOCH(9,6) 34.22 Neutral
STOCHRSI(14) 31.55 Neutral
MACD(12,26) 2.338 Sell
ADX(14) 32.31 Buy
William %R -40.92 Neutral
CCI(14) 36.59 Neutral
Buy: 1 Sell: 1 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
55.85
Buy
54.65
Buy
MA20
52.82
Buy
53.05
Buy
MA50
48.02
Buy
48.34
Buy
MA100
41.06
Buy
42.95
Buy
MA200
33.64
Buy
37.48
Buy
Buy: 10 Sell: 0 Neutral: 0
Summary: Buy
According to our latest analysis, CORT could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 1 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on CORT, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 61.47 indicates that CORT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 34.22 indicates that CORT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 31.55 indicates that CORT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 32.31 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 36.59 indicates that CORT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term CORT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Corcept Therapeutics Inc financial reports and earnings history, Corcept Therapeutics Inc (CORT) stock could reach $37.53 by 2030, $100.90 by 2040 and $136.73 by 2050. See the projected annual prices until 2050 of the Corcept Therapeutics Inc stock below:

  • Corcept Therapeutics Inc (CORT) is expected to reach an average price of $81.07 in 2035, with a high prediction of $83.85 and a low estimate of $79.92. This indicates an $44.97% rise from the last recorded price of $55.92.
  • Corcept Therapeutics Inc (CORT) stock is projected to chart a bullish course in 2040, with an average price target of $100.50, representing an $79.73% surge from its current level. The forecast ranges from a conservative $98.48 to a sky-high $100.90.
  • Our analysts predict Corcept Therapeutics Inc (CORT) to jump 120.24% by 2045, soaring from $120.59 to an average price of $123.16, potentially reaching $123.66. While $120.59 is the low estimate, the potential upside is significant.
  • Corcept Therapeutics Inc (CORT) stock is expected to climb by 2050, reaching an average of $136.70, a $144.46% jump from its current level. However, a wide range of estimates exists, with high and low targets of $136.73 and $133.12, respectively, highlighting the market's uncertainty.

Corcept Therapeutics Inc Stock (CORT) Year by Year Forecast

Corcept Therapeutics Inc Stock (CORT) Price Forecast for 2024

Our forecast for CORT stock price in 2024 now indicates an average price target of $26.61 with a high forecast of $32.37 and a low forecast of $20.84. The average prediction reflects an decrease of -52.42% from the last recorded price of $55.92.
Month Average Low High Change from today's price
December, 2024 $28.24 $26.06 $32.37 -49.50%

Corcept Therapeutics Inc Stock (CORT) Price Forecast for 2025

Corcept Therapeutics Inc Stock (CORT) is expected to reach an average price of $33.25 in 2025, with a high prediction of $40.91 and a low estimate of $25.60. This indicates an -40.53% fall from the last recorded price of $55.92.
Month Average Low High Change from today's price
January, 2025 $27.36 $27.00 $29.04 -51.07%
February, 2025 $28.20 $26.95 $29.03 -49.57%
March, 2025 $28.18 $28.11 $30.03 -49.61%
April, 2025 $27.83 $25.60 $29.03 -50.24%
May, 2025 $28.57 $27.06 $29.18 -48.91%
June, 2025 $30.50 $28.25 $30.77 -45.46%
July, 2025 $32.89 $30.47 $33.27 -41.18%
August, 2025 $33.43 $33.25 $35.29 -40.22%
September, 2025 $31.10 $30.22 $34.06 -44.39%
October, 2025 $37.41 $29.52 $40.91 -33.10%
November, 2025 $35.06 $34.02 $37.83 -37.31%
December, 2025 $34.71 $34.45 $36.96 -37.93%

Corcept Therapeutics Inc Stock (CORT) Price Forecast for 2026

The predicted value for Corcept Therapeutics Inc (CORT) in 2026 is set at an average of $42.32. Estimates vary from a peak of $49.99 to a trough of $34.65, indicating an -24.31% surge from the present price of $55.92.
Month Average Low High Change from today's price
January, 2026 $41.14 $34.65 $42.37 -26.43%
February, 2026 $44.61 $40.73 $45.47 -20.22%
March, 2026 $46.73 $43.94 $46.95 -16.43%
April, 2026 $45.81 $45.55 $49.99 -18.08%
May, 2026 $44.71 $42.00 $46.15 -20.05%
June, 2026 $41.99 $41.55 $45.30 -24.91%
July, 2026 $40.82 $39.07 $43.99 -27.01%
August, 2026 $41.34 $40.74 $42.20 -26.08%
September, 2026 $42.12 $40.93 $43.35 -24.67%
October, 2026 $42.13 $39.88 $42.29 -24.65%
November, 2026 $41.80 $40.45 $42.33 -25.24%
December, 2026 $40.48 $40.48 $42.41 -27.61%

Corcept Therapeutics Inc Stock (CORT) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Corcept Therapeutics Inc (CORT) is $45.39, with a high forecast of $53.49 and a low forecast of $37.29. This indicates an -18.83% decrease from the last price of $55.92.
Month Average Low High Change from today's price
January, 2027 $39.74 $39.54 $42.55 -28.93%
February, 2027 $44.11 $38.65 $45.18 -21.12%
March, 2027 $40.38 $37.29 $44.89 -27.79%
April, 2027 $40.19 $39.77 $42.57 -28.13%
May, 2027 $41.37 $38.32 $41.54 -26.02%
June, 2027 $45.91 $41.09 $46.57 -17.91%
July, 2027 $44.98 $44.49 $47.90 -19.57%
August, 2027 $45.00 $44.76 $48.30 -19.53%
September, 2027 $43.95 $40.03 $45.54 -21.40%
October, 2027 $43.87 $43.34 $45.03 -21.54%
November, 2027 $51.04 $43.98 $51.13 -8.73%
December, 2027 $52.08 $48.83 $53.49 -6.86%

Corcept Therapeutics Inc Stock (CORT) Price Forecast for 2028

In 2028, Corcept Therapeutics Inc (CORT) is projected to reach an average price of $49.00, with a high projection of $54.58 and a low estimate of $43.41. This indicates an -12.38% fall from the last price of $55.92.
Month Average Low High Change from today's price
January, 2028 $49.52 $49.38 $52.16 -11.44%
February, 2028 $49.75 $48.58 $50.73 -11.03%
March, 2028 $52.99 $49.48 $53.68 -5.24%
April, 2028 $50.71 $48.81 $54.58 -9.32%
May, 2028 $45.54 $44.42 $50.59 -18.57%
June, 2028 $49.04 $44.78 $49.09 -12.31%
July, 2028 $48.33 $47.45 $50.14 -13.58%
August, 2028 $46.30 $43.41 $48.66 -17.19%
September, 2028 $48.12 $46.11 $48.87 -13.96%
October, 2028 $50.12 $47.54 $50.24 -10.38%
November, 2028 $49.58 $49.13 $51.88 -11.33%
December, 2028 $48.79 $47.74 $50.57 -12.74%

Corcept Therapeutics Inc Stock (CORT) Price Forecast for 2029

The 2029 price forecast for Corcept Therapeutics Inc Stock (CORT) is $49.27 on average, with a high prediction of $61.54 and a low estimate of $36.99. This represents an -11.90% decrease from the previous price of $55.92.
Month Average Low High Change from today's price
January, 2029 $52.30 $48.37 $52.49 -6.47%
February, 2029 $58.77 $51.69 $59.18 +5.10%
March, 2029 $60.73 $58.27 $61.54 +8.60%
April, 2029 $55.04 $52.52 $60.83 -1.57%
May, 2029 $52.79 $52.21 $56.72 -5.60%
June, 2029 $53.95 $52.25 $54.16 -3.52%
July, 2029 $60.68 $53.87 $61.48 +8.51%
August, 2029 $49.58 $49.48 $55.85 -11.34%
September, 2029 $51.15 $49.40 $54.64 -8.54%
October, 2029 $53.47 $51.11 $53.97 -4.38%
November, 2029 $52.14 $51.75 $55.18 -6.75%
December, 2029 $37.06 $36.99 $53.97 -33.73%

Corcept Therapeutics Inc Stock (CORT) Price Forecast for 2030

Corcept Therapeutics Inc Stock (CORT) is expected to reach an average price of $41.75 in 2030, with a high forecast of $47.26 and a low forecast of $36.24. This signifies an -25.34% decrease from the last price of $55.92.
Month Average Low High Change from today's price
January, 2030 $37.33 $36.24 $37.53 -33.25%
February, 2030 $38.00 $37.32 $38.65 -32.04%
March, 2030 $40.29 $37.98 $40.39 -27.95%
April, 2030 $40.78 $39.84 $41.36 -27.07%
May, 2030 $42.90 $40.50 $43.68 -23.27%
June, 2030 $43.74 $42.42 $43.84 -21.78%
July, 2030 $42.71 $40.95 $47.26 -23.63%
August, 2030 $42.76 $42.55 $44.09 -23.54%
September, 2030 $42.98 $42.23 $43.12 -23.14%
October, 2030 $44.51 $42.94 $45.47 -20.41%
November, 2030 $42.13 $41.48 $45.70 -24.66%
December, 2030 $43.68 $41.48 $44.56 -21.88%
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Cap:     |  Volume (24h):